Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study

dc.contributor.authorErdem, Erim
dc.contributor.authorEfesoy, Aysun
dc.contributor.authorSaylam, Barış
dc.date.accessioned2023-04-10T20:20:56Z
dc.date.available2023-04-10T20:20:56Z
dc.date.issued2021
dc.departmentRektörlük, Rektörlüğe Bağlı Birimler, Düzce Üniversitesi Dergilerien_US
dc.description.abstractAim: The study aims to investigate the clinical course of symptomatic physiological hydronephrosis in pregnant women and the results of treatment in patients required treatment. Material and Methods: A hundred and two consecutive pregnant women who presented with clinical signs and symptoms related to the upper urinary system were included in the study. Renal ultrasonography, urinalysis, serum creatinine levels, white blood cell count, and urine culture were done in all patients at the first visit and repeated at least once a month until 1 month after delivery. In patients with acute pyelonephritis, urinalysis was repeated every 3 days until white blood cell count, erythrocyte sedimentation rate and C-reactive protein levels normalized; urine culture and kidney ultrasonography were performed monthly until 1 month after delivery. Conservative measures (positioning, analgesia, antibiotics) were used in all patients with symptomatic physiological hydronephrosis. If the patient's condition was resistant to medical treatment and the degree of hydronephrosis was increased, drainage was performed by inserting a double J stent into the ureter. Results: Conservative treatments were successful in 98 (96.1%) of 102 patients, but 4 (3.9%) had signs and symptoms of acute pyelonephritis progressing to urosepsis. Antibiotics were continued in patients who developed pyelonephritis, symptoms regressed rapidly, signs of kidney infection returned to normal. Follow-up pregnancies ended with normal vaginal delivery. Conclusion: Symptomatic hydronephrosis in pregnancy can be treated conservatively, should be treated carefully and patients should be followed up. However, ureteral double-J stenting is an effective and safe treatment method in patients with resistant symptoms.en_US
dc.identifier.doi10.18678/dtfd.917116
dc.identifier.endpage173en_US
dc.identifier.issn1307-671X
dc.identifier.issue2en_US
dc.identifier.startpage170en_US
dc.identifier.trdizinid498456en_US
dc.identifier.urihttp://doi.org/10.18678/dtfd.917116
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/498456
dc.identifier.urihttps://hdl.handle.net/20.500.12684/11483
dc.identifier.volume23en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHydronephrosis pregnancyen_US
dc.titleClinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
11483.pdf
Boyut:
362.23 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text